Sun Pharmaceutical Industries Limited is taking this opportunity to balance employment and the medications to the world. We are hereby inviting candidates who are interested to join India's No. 1 company in Pharmaceutical sector.

Post : Senior Officer - Senior Executive

Department : QMS - Production (Parenteral) 
Experience : 5 - 10 years
Qualification : B.Pharma / M.Pharma / M.Sc 

National Institute of Biomedical Genomics (NIBMG) Kalyani is an Institute of Government of India, Ministry of Science & Technology, Department of Biotechnology. The Institute has created necessary physical infrastructure and critical platform technologies to support research, translation, and training in biomedical genomics.

Post : Post Doctoral Fellow / Research Associate

NMDC Limited, a Navaratna Public Sector Enterprise under the Ministry of Steel, Government of India and a multi locational, Multi product and consistently profit making Mining & Mineral Exploration Organization with large turnover. NMDC is in the process of massive expansion and diversification both in India and abroad.

Post : Graduate Apprentices (Bachelor of Pharmacy*)

NIAB, an autonomous institute under the aegis of the Department of Biotechnology, Ministry of Science & Technology, Government of India, is aimed to harness novel and emerging biotechnologies and create knowledge in the cutting edge areas for improving animal health and productivity. The Institute’s research focus is on animal genetics and genomics, transgenesis, stem cell & its applications, reproductive biotechnology, infectious diseases, nanotechnology, bioinformatics and Nutrigenomics.

Jawaharlal Nehru University is the foremost university in India, and a world-renowned centre for teaching and research. Ranked number one in India by the National Assessment and Accreditation Council (NAAC) with a Grade Point of 3.91 (on a scale of 4), JNU was ranked no 3 among all universities in India by the National Institutional Ranking Framework, Government of India, in 2016 and no 2 in 2017. JNU also received the Best University Award from the President of India in 2017.

Post : Research Associate I (One)

The Central University of Odisha has been established by the Parliament under the Central Universities Act, 2009 (No. 3C of 2009). It is one of the 15 new Central Universities established by the Government of India during the UGC XI Plan period to address the concerns of "equity and access" and as per the policy of the Government of India to increase the access to quality higher education by people in less educationally developed districts which have a Graduate Enrollment Ratio of less than the national average of 11%. 

The Rajiv Gandhi Centre for Biotechnology (RGCB) is a growing phenomenon. Located in Thiruvananthapuram, the capital city of Kerala, RGCB began in 1990 amongst humble surroundings as a small charitable society called the Centre for Development of Education, Science and Technology (C-DEST).

MACS - Agharkar Research Institute  (ARI)  an  autonomous  Institute  of  the  Department  of Science and Technology (DST), Government of India is committed to the promotion of science and technology with emphasis on high standards of research and development activities for the benefit  of  humankind  and  the  nation.  The  current  research  activities  encompass  biological sciences   and   focus   on   six   thematic&

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Pool Campus Drives Hiring Freshers

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.

OSD Formulation - Quality Control / Method Validation (Fixed Term Contract -1 Year)

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. IPCA is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, IPCA is one of the worlds largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the worlds most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services, and Accenture Song all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 699,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Production
Qualifications : B.Sc, Chemistry, B.Com / M.Sc. 
Experience : 2-8 Years Pharma API Experience Mandatory.
Post : Junior Executive / Executive 

Alkem Laboratories Limited established in 1973, is amongst the top five leading Indian Pharmaceutical Companies with global operations, engaged in the development, manufacturing and sale of Pharmaceutical and Nutraceutical Products, which are marketed in India and 50 countries internationally, primarily in the United States.

WALK IN INTERVIEW for Formulation Manufacturing Facility based at Daman

Department : Production & Packing

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries.

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of COVID-19, long COVID and possibly other viruses.

Researchers at Leipzig University and Ulm University have developed a new method to isolate HIV from samples more easily, potentially making it easier to detect infection with the virus. They focus on peptide nanofibrils (PNFs) on magnetic microparticles, a promising tool and hybrid material for targeted binding and separation of viral particles. They have published their new findings in the journal Advanced Functional Materials.

Bristol Myers Squibb announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to severe active Crohn’s disease. The study did not meet its primary endpoint of clinical remission at Week 12.

Technology Information, Forecasting & Assessment Council (TIFAC), an Autonomous Body under the Department of Science and Technology (DST), Government of India invites applications from Indian Nationals for engagement of Two (02) Young Professionals for executing the (STUDY ON TECHNO COMMERCIAL ASSESSMENT OF TRL-6) on full time contract and on consolidated remuneration (Professional fee) basis. The duration of the study is one year.